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Summary.-The relationship of serum carcinoembryonic antigen (CEA) levels to
tumour size and antigen content was studied in nude mice bearing well differentiated,
mucinous human colonic-tumour xenografts. Blood samples were taken from normal
nude mice and others bearing xenografts, whose size had been calculated from in
vivo measurements; saline and KCI extracts were made of a proportion of these
tumours. Sera and tissue extracts were assayed for CEA activity by double-antibody
radioimmunoassay. Extracts were also made from the livers and spleens of tumour-
bearing and normal nude mice.
All normal sera and 78% of sera from tumour-bearing animals had CEA values
< 11 4 ng/ml. No clear correlation was found between serum CEA levels >11.4 ng/ml
and tumour size or weight, or between serum CEA and tumour CEA concentrations
or total CEA burden. The concentration of CEA in those tumours tested varied from
1 to 22 /Lg/g.
Our results confirm and extend the conclusions reached by others (Stragand
et al., 1980) studying the significance of serum CEA levels with xenograft model
systems. The complexity of factors contributing to circulating CEA is discussed in
the light of our findings.
DURING RECENT YEARS much attention
has been focused on the relationship
betweencirculatingcarcinoembryonic anti-
gen (CEA) levels and various aspects of
colorectal tumour biology (e.g. size, degree
of differentiation, extent of metastatic
spread). However, it is difficult to draw
many firm conclusions from the consider-
able volume of published data. Some
studies have shown that circulating CEA
levels may not be directly related to
tumour size (Reynoso et al., 1972; Holyoke
et al., 1972) although it must be said that
measurement oftumour size in the patient
is extremely difficult. A lack of correlation
has also been reported between circulating
CEA levels and the degree of tumour dif-
ferentiation (Dhar et al., 1975; Bivins et
al., 1975) or tumour CEA content (Gallo
et al., 1977; Khoo et al., 1973; Goldenberg
et al., 1976b; McClendon et al., 1977).
Several authors, however, have suggested
that circulating CEA levels more accur-
ately reflect the general extent of disease
(Dhar et al., 1975; Zamcheck et al., 1975;
Breuer et al., 1980) and that this may, in
part, be a result of the degree of necrosis
and vascular invasion within the tumour
(Bivins et al., 1975; Zamcheck et al., 1975;
Breuer et al., 1980).
It is surprising, therefore, that very few
studies have been published using in vivo
model systems-especially colonic-tumour
xenografts. One widely quoted study of
nude mice bearing well differentiated
colonic-tumour xenografts proposed that
serum CEA levels were indeed directly
proportional to tumour size (Miwa et al.,
1976, 1977; Kubota et al. 1978). However,
little reliance, if any, can be placed on
this conclusion, given the low number of
samples (5). Other authors mentioning aJ. C. M. LEWIS AND P. A. KEEP
similar relationship have also based their
findings on very low sample numbers
(Mach et al., 1974). In contrast, a much
larger study (Stragand et al., 1980), using
nude mice bearing "LoVo" colonic-tumour
xenografts, demonstrated no correlation
between tumour size and serum CEA.
Similar findings have been reported for
immune-deprived mice bearing xenografts
of breast carcinoma (Davies & Steel,
1978). It has also been found that blood
AFP levels in immune-deprived mice bear-
ing human malignant teratoma xenografts
did not correlate well with tumour size
(Raghavan et al., 1980).
The present work was conducted to
assess the relationship between circulating
CEA levels and tumour size, weight, CEA
concentration and total tumour CEA
burden in nude mice bearing a well differ-
entiated mucinous colonic-tumour xeno-
graft (P1 16), and to assess the varization of
CEA concentration within an apparently
stable xenograft line. In making extracts
of several tissues from both tumour-
bearing and normal nude mice, it was our
intention to define extra-tumour sites of
CEA retention in tumour-bearing animals,
and determine whether normal tissues of
the nude mouse express cross-reacting
antigens undetectable in serum assays.
MATERIALS AND METHODS
Outbred female athymic nude (nu/nu) mice
were maintained in a clean convenitional
environment and fed irradiated diet and
chlorinated (_ 1/106 chlorine) water ad
libitum. Tumour material was implanted s.c.
under ether at 10 weeks of age, and normal
control animals used at 20 weeks.
The P116 xenograft line maintained at
Charing Cross Hospital was originally estab-
lished in immune-deprived mice (Cobb), 1973).
Over serial passage in nude mice the histo-
logical appearance has varied little and con-
sists of moderately wNell differentiated adeno-
carcinoma cells forming clumps, gland-like
structures and single layers w-ith abundant
FiG. 1. Photomicrograph of P116 xenograft of the 5th passage. H. & E. x 65.
382CEA IN XENOGRAFT AND SERUM
extracellular mucin secretion (Fig. 1). Central
necrosis is a consistent feature. The tumours
in nude mice are surrounded by and invested
peripherally with a fibrous stroma containing
typically a moderate and patchy chronic
inflammatory infiltrate. Metastasis has not
been seen in tumour-bearing animals.
Fifty-five mice bearing xenografts of the
5th and 6th passages were bled under ether
anaesthesia from the retro-orbital venous
sinus at various times after xenografting.
Blood samples were similarly taken from 18
control animals. Serum was separated by
centrifugation after overnight clotting at
room temperature. Tumours were measured
in 3 dimensions with calipers (L, W & H),
tumour volumes estimated as LWH/2
(Looney et a., 1973) and weights estimated
from previously constructed calibration
curves. Estimated tumour weights ranged
from 0-02 g to 7-20 g with a mean of 1-08 g.
Eleven of the 55 tumour-bearing mice and
5 control mice were killed by cervical disloca-
tion after bleeding, and tumours, livers and
spleens removed. All organs were weighed,
and a small sample of each tumour fixed in
10% formalin for subsequent histological
examination. Tumours were then reweighed.
Whole tumour weights ranged from 0-16 to
7-14 g (mean 1-61 g).
Tissuesamples werehomogenizedinphysio-
logical saline and the homogenates centri-
fuged at 75,000 g for 30 min. Supernatants
were dialysed against twice-daily changes of
tap water at 4°C for 72 h, and concentrated
to 5 ml by ultrafiltration. Samples were
centrifuged for a second time at 75,000 g, 30
min, and the supernatants stored at -20°C
with 0 02% sodium azide, after recording
their volumes. These samples were designated
saline extracts.
Homogenate sediments produced by the
first ultracentrifugation were washed once
with physiological saline and extracted for
72 h with an excess of 3M KCI. Extracts were
centrifuged, dialysed, concentrated, re-centri-
fuged and stored as above. These samples
were designated KCI extracts.
CEA levels in tumour and normal-tissue
extracts and serum samples were measured
by double-antibody radioimmunoassay. CEA
isolated from hepatic metastases of colonic
tumours by perchloric acid extraction and
purification on Sepharose 6B and Sephadex
G-200 (Keep et al., 1978) (Preparation M12)
was used as standard (8 doubling dilutions of
25
top standard 500 ng/ml CEA). The CEA
preparation used as label was extracted as
above and purified further on Con A-
Sepharose (Keep et al., 1978) and designated
CEA-2B. Jodination was carried out by a
modification of the Chloramine T technique
(Greenwood et al., 1963) yielding a specific
activity of 179 ,uCi/ptg protein.
The primary antiserum (PkIG (D2)) was
raised in a goat to CEA-2B, then absorbed
with normal human plasma and perchloric
acid extracts of normal human spleen, colon
and liver in immunoabsorbent columns. The
absorption was monitored by rocket immuno-
electrophoresis of the absorbed antiserum
against a 20mg protein/ml solution of each
normal human tissue. The absence of rockets
was taken to indicate lack of cross-reaction.
Precipitation of the CEA-anti-CEA com-
plexes was achieved with second antibody
(BW402 horse anti-(goat+sheep)).
For the tumour and normal-tissue extracts
(buffer-based system) 10 zero-antigen tubes
(maximum binding of label) were set up with
buffer (0-05M phosphate, pH 6, containing
BSA (0.1% w/v) and EDTA (3.4 mM);
200 ,ul), primary antiserum (dilution 1/4400;
50 [I) and CEA label (80,000 ct/min; 50 jul).
Into 10 nonspecific binding tubes were placed
buffer (250 IlI) and label (50 pl) only. The
standards, and samples at appropriate dilu-
tions in buffer were set up in triplicate con-
taining standard/sample (100 ,ul), buffer
(100 ,tl), primary antiserum (50 ,ul) and label
(50 ,u). Incubation was allowed to proceed
for 16 h at 37°C and then second antibody
(dilution 1/40; 50 plI) added. After a further
incubation at 37°C for 8 h the bound fraction
was obtained. Filtration, counting and
analysis was performed on the Kemtek 3000
automated radioimmunoassay system.
Measurement of serum samples was essen-
tially as described above, except that all
samples (in triplicate) were assayed directly
at dilution 1/4. Insufficient serum was avail-
able to assay neat serum in triplicate. Buffer
(100 pl) was added to the samples and normal
nude mouse serum (nu/nu) at dilution 1/4
(100 pl) added to the zero-antigen, non-
specific binding and standard tubes.
Doubling dilutions of each sample were
measured to ensure a parallel response to the
standard line. The interassay coefficient of
variation was 13%. Since the sensitivity of
the radioimmunoassay was 2-85 ng/ml and
the serum samples were all measured at
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dilution 1/4, the lower cut-offpoint was set at
a CEA value of 11L4 ng/ml. This was not taken
to represent the upper limit of serum CEA in
normal nude mice but rather as the lowTer
limit of detection in the diluted serum
samples, necessitated by our insistence upon
triplicated assays.
Tumour samples fixed in formalin wNere
embedded in paraffin wax and 5,UM sections
cut and stained with haematoxylin and eosin
by conventional methods.
RESULTS
The histological appearance of all
tumour samples was typical of the xeno-
graft line (as described in Materials and
Methods).
All sera from control animals and 43 of
the 55 sera from tumour bearers had CEA
values < 11b4 ng/ml. The remaining 12
showed values ranging from 13-9 to
47-8 ng/ml (and tumour weights 0 22-
7*14 g). No clear correlation was found
between the serum CEA values andtumour
size or weight (Fig. 2). However, all
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FIG. 2. SeruLm earcinoembryonic antigen
levels vs tumour weight in xenograft-
bear-ing nu(le mice. (55 points, 12 > I 14 ng.)
animals bearing tumours > 2 15 g had
raised serum CEA values. The coefficient
of correlation (r) between serum CEA
(when > 11 4 ng/ml) and tumour weight
was 0 46.
Tumour CEA concentration varied be-
tween 1 and 22 pg/g wet weight of
tumour (total CEA extracted by the two
methods) and, in the 11 animals studied,
neither tumour CEA concentration nor
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TABLE
Total
tumour
Tumour Tumour CEA
weighit (CEA) bur(le
(g) (Mglg) (Mg)
0 16 1-16 0-17
0-22 20 43 4 58
0.39 13 62 5.35
0-79 2X2-02 17 42
1 10 14 43 15 89
1-16 21-05 24.44
1-16 4-86 5 65
1-50 2 90 4:34
1 96 3 24 6 35
2 14 12-18 26 08
7 14 13 69 97.74
SerIum
CEA
(ngl/ml)
<11 4
16 3
< 11.4
<11-4
<11 4
<11 4
<11 4
<11 4
<11.4
<11 4
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total tumour CEA burden (CEA concentra-
tion x tumour weight) appeared to corre-
late with serum CEA values (Table).
However, we feel that firm conclusions on
this point cannot be drawn from the data
presented owing to the low number of
serum CEA values > 11 4 ng/ml in the
group of animals from which extracts
were made (2/11). There was no correla-
tion between tumour CEA concentration
and tumour weight or size (r= -001).
Liver and spleen extracts from control
animals were negative for CEA. CEA was
detected in KCI extracts of the livers of
2 tumour-bearers only (Tumours 6 & 11 in
the table, with 0 08 [g CEA/g liver and
0d16 jug CEA/g liver respectively) and in
none of the saline extracts. Saline extracts
of spleens from 2 tumour-bearers were
positive for CEA (Tumours 10 and 11 in
the table, with 0 25 jg CEA/g spleen and
0 85 Hg CEA/g spleen respectively), and
KCI extracts were all negative. The
presence of CEA in the non-tumoral
organs of tumour-bearing mice appeared
to be correlated with high total tumour-
CEA burden, but not with high tumour-
CEA concentration, nor with high serum
CEA. However, with so few positive values
for these tissues, firm conclusions cannot
be made from the data.
DISCUSSION
Our study demonstrates a lack of corre-
lation between serum CEA values and
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tumour weight or size in nude mice bearing
P116 colonic-tumour xenografts. With an
assay cut-off of 11 4 ng/ml, small increases
in serum CEA of tumour-bearing nudes
may have gone undetected, artificially
reducing the proportion of "positive"
sera reported in our sample. It is possible,
therefore, that the correlation coefficient
between serum CEA and tumour weight
may be greater than the 0 46 quoted.
However, it remains apparent from the
spread of serum CEA values shown in
Fig. 2 that these values cannot be used
to predict tumour weight or size, even if a
proportion of sera at < 11-4 ng CEA/ml
were in fact to range between 0 and 114 ng
according to tumour weight. It is further
suggested that in this model neither the
tumour CEA concentration nor total
tumour CEA burden correlate with serum
values. These results are in agreement
with those of Stragand et al. (1-980). It
is possible, though, that CEA in serum
samples coutld be undetected in a direct
radioimmunoassay owing to the presence
ofnude mouse anti-CEA immunoglobulins
formed in response to the xenograft. Anti-
CEA (IgM) has been detected in hamsters
bearing G(W39 colonic tumour xenografts
(Primus et al., 1973b; Primus et al., 1976)
and, although the humoral immune re-
sponses ofnude mice are severely impaired
by the lack of functional T cells, it is
conceivable that IgM and/or IgG anti-
CEA could be elaborated to what is, in
effect, a depot preparation of CEA.
Perhaps ofmore importance, the present
work also demonstrates the wide range
(22-fold) of CEA concentration to be
found in examples of a single, apparently
stable, xenograft line, and that this varia-
tion is not simply a function of tumour
size. Whlilst there is plenty of evidence for
the widely varying concentrations of CEA
in human colorectal carcinomas (Dyce &
Haverback, 1974; Sharkey et al., 1 977;
Khoo et al., 1973; WVarner et al., 1973) and
that differences may exist in regional CEA
concentration within a single tumour
(Wagener & Breuer, 1978), previous work
with single xenograft lines suggests that
the concentration of antigen in these
models varies little from tumour to tumour
(Munjal & Goldenberg, 1976; Chao et al.,
1974; Miwa et al., 1977, 1976) a 4-fold
variation being the highest quoted (Carrel
et al., 1976). It remains to be seen whether
different methods of xenografting and
maintaining xenograft lines produce
tumours ofdiffering stabilities with respect
to antigen content.
It has become apparent that the level
of circulating CEA found in patients with
colorectal carcinoma is a function not
only of tumour size, but also of many
other features of tumour and host biology
(Goldenberg et al., 1976a). The proportion
of a tumour's cell population producing
and excreting CEA clearly plays an impor-
tant role. From in vitro studies, the highest
cellular content and maximum production
of CEA by colorectal-carcinoma cells is
seen in the stationary or G phase of the
cell cycle, whereas, conversely, exponen-
tially growing cell populations have rela-
tively low CEA content. However, release
of CEA is not necessarily related to cell-
cycle phase (Drewinko & Yang, 1976,
1980; Cohen & Wrood, 1979). Tumour CEA
concentration and total CEA burden will
therefore be heavily dependent upon the
kinetics of cell cycling within individual
tumours, although the rate of CEA release
need not necessarily be proportional to
tumour CEA concentration and total CEA
burden. It has also been suggested that
CEA may be released during or after cell
death (Bivins et al., 1975; Davies & Steel,
1978; Breuer et al., 1980); if so, the cell-
loss rate of a tumour would also influence
rate of CEA release. It is reasonable to
suggest that levels of circulating CEA will
also be affected by the relative partitioning
of released CEA between the tumour
interstitium, blood vascular space and gut
lumen (for primary tumours (Molnar et al.,
1976)). Not surprising, therefore, is the
finding that the degree of vascularization
(Bivins et al., 1975; Sharkey et al., 1977;
Zamcheck et al., 1975) and lymphatic
invasion (Zamcheck etal., 1975) oftumours
can be loosely related to plasma CEA
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levels. Finally, host metabolism and
degradation of CEA will affect circulating
levels. Clearance of circulating CEA is
thought to be mediated primarily by the
liver (Shuster et al., 1973; Primus et al.,
1973a), possibly by the hepatocytes. Thus
depressed hepatic function may maintain
circulating CEA at abnormally high levels,
and the relative importance of CEA
derived from normal gastrointestinal-tract
cells may be increased (review by Loewen-
stein & Zamcheck, 1977). Decreased
plasma CEA clearance may also result
from the presence of circulating immune
complexes formed between CEA and auto-
logous anti-CEA (Primus et al., 1973a,
1974) at least in experimental systems,
although the significance of this in the
human is as yet undetermined.
Given this complex array of factors
potentially influencing circulating CEA
levels, it is perhaps not surprising that no
simple relationship exists between serum
CEA and tumour size, weight, CEA con-
centration or tumour CEA burden in our
system. The xenografts used show marked
individual variation in CEA content; the
exact degree of vascular invasion and
necrosis varies from tumour to tumour (as
judged by histological examination of
tumour sections) and other relevant
features such as host response and cell-
cycle kineticfactors mayvaryfromtumour
to tumour, though we have not yet exam-
ined these. This is not to say that xeno-
grafts are inappropriate models for the
study of CEA metabolism. It may be
necessary for future studies of circulating
CEA, and its relationship to aspects of
tumour biology, to assess such features
sequentially in individual xenograft-bear-
ing animals, rather than across a popula-
tion of such tumours.
The authors are indebted to Mr F. Gowali for his
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paign and the Medical Research Council.
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